Impact of COVID-19 on business activities and performance
First written in FY2020. 13 of 18 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2026DroppedAnnual reportBusiness and other risks for the fiscal year comprise 6 items: key markets, raw materials, foreign exchange, interest rates, securities held and disasters. COVID-19 is not listed as a standalone risk.
- FY2026-H1RestatedAnnual report
「During the current interim consolidated accounting period, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no material changes to business and other risks, including COVID-19. - FY2025-H1RestatedAnnual report
「During the current interim consolidated accounting period, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no material changes to business and other risks, including COVID-19. - FY2024-Q3RestatedAnnual report
「During the nine-month cumulative consolidated period under review, there were no new business or other risks, and no material changes to the business or other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no material changes to business and other risks, including COVID-19. - FY2024-Q2RestatedAnnual report
「During the first six months of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no material changes to business and other risks, including COVID-19. - FY2024-Q1RestatedAnnual report
「During the first quarter of the current consolidated fiscal year, there were no newly arising business or other risks, and no material changes to the business or other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no material changes to business and other risks, including COVID-19. - FY2023RestatedAnnual report
「The Company will continue to prioritize the safety of employees and business partners, work to prevent infections and implement necessary measures, and continue its business activities to minimize the impact.」
Alongside the statement that the business is recovering from the impact of COVID-19, the Company continues measures to ensure the safety of employees and business partners, prevent infections and maintain business continuity. - FY2023-Q3RestatedAnnual report
「During the nine-month cumulative consolidated period under review, there were no new business or other risks, and no material changes to the business or other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no material changes to business and other risks, including COVID-19. - FY2023-Q2RestatedAnnual report
「During the first six months of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no material changes to business and other risks, including COVID-19. - FY2023-Q1RestatedAnnual report
「During the three-month period ended 30 June 2022 (from 1 April 2022 to 30 June 2022), Japan's economy gradually normalized as vaccination progressed while the impact of COVID-19 continued, but the situation is expected to remain severe because the resurgence of COVID-19 due to new variants was accompanied by a weaker yen and rising prices.」
While economic activity is normalizing, the impact of COVID-19, including its resurgence due to new variants, continues, and the Company continues to identify business and performance risks from COVID-19. - FY2022RestatedAnnual report
「If a resurgence of COVID-19 causes disruption to the production, logistics or sales activities of the Group, or if human losses increase, it may affect the Group's business results.」
The Company continues to identify the risk of disruption to production, logistics and sales activities and human losses resulting from a resurgence of COVID-19. While describing the recovery of economic activity, it remains concerned about a renewed spread caused by new variants. - FY2022-Q3RestatedAnnual report
「Although the steel industry, the largest source of demand for refractories, is showing signs of recovery, there are no signs that COVID-19 is being contained, and the uncertain outlook is expected to continue.」
While describing signs of recovery in the steel industry, the Company continues to state that there are no signs of COVID-19 being contained and that the outlook remains uncertain. - FY2022-Q2RestatedAnnual report
「The extension and reissuance of states of emergency due to the spread of variant strains, the impact of US-China trade friction and semiconductor shortages on the automotive sector, and the risk of price volatility from sharp increases in resource prices and logistics costs remain concerns. Accordingly, uncertain conditions are expected to persist.」
While describing signs of containment of COVID-19 and an economic recovery, the Company continues to identify the spread of COVID-19 variants and the extension or reissuance of a state of emergency as concerns. - FY2022-Q1RestatedAnnual report
「During the three-month period ended 30 June 2021 (from 1 April 2021 to 30 June 2021), Japan's economy remained weak, with no clear prospect of containing COVID-19, although signs of recovery continued, particularly in manufacturing, including the automotive sector.」
While stating that containment of COVID-19 remains uncertain, the Company also describes a recovery centered on manufacturing. It expressly states that there has been no material change in the business and performance risks associated with COVID-19. - FY2021-Q3WorsenedAnnual report
「The situation is expected to remain unstable because COVID-19 continues to spread worldwide, while risks of a downturn in the economy and steel demand remain, including the growing global trend toward protectionism and geopolitical risks. Revenue was ¥16,860 million, down 22.5% year on year, owing to lower demand for refractories resulting from continued production cuts in the domestic and overseas steel industries.」
The spread of COVID-19 and instability in the global economy continued, and revenue fell 22.5% year on year through continued production cuts in the domestic and overseas steel industries and lower demand for refractories. The impact of COVID-19 continues to materialize in business performance. - FY2021-Q2WorsenedAnnual report
「Revenue was ¥10,956 million, down 24.3% year on year, owing to lower demand for refractories resulting from continued production cuts in the domestic and overseas steel industries.」
Production cuts in the domestic and overseas steel industries continued amid the spread of COVID-19, and revenue for the six-month period ended the second quarter fell 24.3% year on year through lower demand for refractories. The impact of COVID-19 continues to materialize in business performance. - FY2021-Q1MaterialisedAnnual report
「Other revenue was significantly affected by the spread of COVID-19, amounting to ¥73 million, down 19.5% year on year. The segment recorded a loss of ¥1 million, compared with a profit of ¥40 million in the same period of the previous year.」
The impact of the spread of COVID-19 has materialized in the "Other" business as a decline in revenue and a swing from profit in the same period of the previous year to a loss. - FY2020First statedAnnual report
「If the global spread of the novel coronavirus causes disruption to the production, logistics or sales activities of the Group, or if human losses increase, it may affect the Group's business results.」
The spread of COVID-19 was identified for the first time as a standalone business and other risk, citing possible disruption to production, logistics and sales activities and possible human losses. Although the global spread itself has occurred, no specific disruption to the Group is described.